Serum melatonin concentrations in coronary heart disease patients with hypercholesterolaemia

  • Editorial Office

Abstract

This investigation was undertaken to determine the serum melatonin concentrations in coronary heart disease patients (CHD) with hypercholesterolaemia. Hypercholesterolaemia is a contributing factor to atherogenesis in CHD. Melatonin suppresses cholesterol synthesis. The preliminary results indicate that melatonin levels seem to be suppressed in CHD patients with hypercholesterolaemia.
Published
2001-09-28
Section
Research Letter